McIlrath & Eck »

Verve Therapeutics shares owned by McIlrath & Eck

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by McIlrath & Eck from 13F filings

Historical chart of McIlrath & Eck investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by McIlrath & Eck consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by McIlrath & Eck

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0k 75 13.95
2023-09-30 $995 75 13.27
2023-06-30 $1.4k 75 18.75
2023-03-31 $1.1k 75 14.43
2022-12-31 $1.5k 75 19.35
2022-09-30 $3.0k 75 40.00
2022-06-30 $999 75 13.33
2022-03-31 $2.0k 75 26.67
2021-12-31 $3.0k 75 40.00
2021-09-30 $4.0k 75 53.33